Brookstone Capital Management Grows Position in Healthpeak Properties, Inc. $DOC

Brookstone Capital Management boosted its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 4.9% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 566,362 shares of the real estate investment trust’s stock after acquiring an additional 26,649 shares during the quarter. Brookstone Capital Management’s holdings in Healthpeak Properties were worth $9,917,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of DOC. Envestnet Portfolio Solutions Inc. raised its position in Healthpeak Properties by 16.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 49,398 shares of the real estate investment trust’s stock worth $999,000 after acquiring an additional 6,869 shares in the last quarter. Kentucky Retirement Systems Insurance Trust Fund purchased a new position in Healthpeak Properties in the first quarter worth $411,000. Cambridge Investment Research Advisors Inc. raised its position in Healthpeak Properties by 6.9% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 357,520 shares of the real estate investment trust’s stock worth $7,229,000 after acquiring an additional 23,135 shares in the last quarter. AssuredPartners Investment Advisors LLC raised its position in Healthpeak Properties by 3.1% in the first quarter. AssuredPartners Investment Advisors LLC now owns 22,088 shares of the real estate investment trust’s stock worth $447,000 after acquiring an additional 666 shares in the last quarter. Finally, S.A. Mason LLC raised its position in Healthpeak Properties by 160.9% in the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust’s stock worth $30,000 after acquiring an additional 925 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Up 0.1%

DOC opened at $18.60 on Thursday. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. The firm has a market cap of $12.92 billion, a P/E ratio of 77.48, a PEG ratio of 3.17 and a beta of 1.09. Healthpeak Properties, Inc. has a 52 week low of $16.63 and a 52 week high of $23.26. The business’s fifty day simple moving average is $18.26 and its 200 day simple moving average is $17.90.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting analysts’ consensus estimates of $0.46. The business had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The business’s revenue for the quarter was down .2% compared to the same quarter last year. During the same quarter last year, the company earned $0.45 earnings per share. As a group, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 19th will be paid a dividend of $0.1017 per share. The ex-dividend date of this dividend is Friday, December 19th. This represents a c) dividend on an annualized basis and a dividend yield of 6.6%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 508.33%.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on DOC shares. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $18.00 price target (down previously from $28.00) on shares of Healthpeak Properties in a research report on Wednesday, August 20th. Morgan Stanley dropped their price target on Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating for the company in a research report on Friday, August 22nd. Wells Fargo & Company dropped their price target on Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 27th. Wall Street Zen cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Monday, July 7th. Finally, Cantor Fitzgerald started coverage on Healthpeak Properties in a research report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price target for the company. Eight investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties presently has a consensus rating of “Moderate Buy” and a consensus price target of $21.33.

Insider Activity at Healthpeak Properties

In related news, CEO Scott M. Brinker acquired 1,490 shares of the firm’s stock in a transaction that occurred on Monday, August 4th. The shares were acquired at an average price of $16.83 per share, with a total value of $25,076.70. Following the completion of the purchase, the chief executive officer directly owned 211,906 shares in the company, valued at approximately $3,566,377.98. The trade was a 0.71% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders acquired a total of 8,783 shares of company stock worth $150,129 over the last quarter. 0.23% of the stock is owned by company insiders.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.